Myelodysplastic syndromes with del(5q): A real-life study of determinants of long-term outcomes and response to lenalidomide
Blood Cancer J
.
2022 Sep 7;12(9):132.
doi: 10.1038/s41408-022-00724-3.
Authors
Carmelo Gurnari
1
2
3
,
Alfonso Piciocchi
4
,
Stefano Soddu
4
,
Fabrizio Bonanni
1
3
,
Emilia Scalzulli
3
5
,
Pasquale Niscola
3
6
,
Ambra Di Veroli
3
7
,
Anna Lina Piccioni
3
8
,
Monica Piedimonte
3
9
,
Gianluca Maiorana
3
9
,
Prassede Salutari
10
,
Laura Cicconi
3
11
,
Michelina Santopietro
3
12
,
Svitlana Gumenyuk
3
13
,
Chiara Sarlo
3
14
,
Susanna Fenu
3
8
,
Agostino Tafuri
3
9
,
Roberto Latagliata
3
7
,
Luana Fianchi
3
15
,
Marianna Criscuolo
3
15
,
Jaroslaw P Maciejewski
2
,
Luca Maurillo
1
3
,
Francesco Buccisano
1
3
,
Massimo Breccia
3
5
,
Maria Teresa Voso
16
17
18
Affiliations
1
Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.
2
Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
3
GROM-L (Gruppo Romano-Laziale MDS), Rome, Italy.
4
Italian Group for Adult Hematologic Diseases (GIMEMA) Foundation, Rome, Italy.
5
Department of Translational and Precision Medicine-Az., Policlinico Umberto I-Sapienza University, Rome, Italy.
6
Hematology Unit, Sant'Eugenio Hospital, Rome, Italy.
7
Belcolle Hospital, Viterbo, Italy.
8
Hematology Dep, Az. Osp., San Giovanni-Addolorata, Rome, Italy.
9
Hematology, "Sant'Andrea" Hospital-Sapienza, University of Rome, Rome, Italy.
10
Hematology, Pescara Hospital, Pescara, Italy.
11
Hematology, ASL Roma 1, Rome, Italy.
12
Hematology and Hematopoietic Stem Cells Transplant Unit, AO San Camillo-Forlanini, Rome, Italy.
13
Hematology Unit, Department of Research and Clinical Oncology, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
14
Hematology and Stem Cell Transplantation Unit, University Campus Bio-Medico, Rome, Italy.
15
Department of Hematology, Fondazione Policlinico Universitario Agostino Gemelli-IRCCS, Roma, Italy.
16
Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.
[email protected]
.
17
GROM-L (Gruppo Romano-Laziale MDS), Rome, Italy.
[email protected]
.
18
Santa Lucia Foundation, IRCCS, Neuro-Oncohematology, Rome, Italy.
[email protected]
.
PMID:
36071048
PMCID:
PMC9452671
DOI:
10.1038/s41408-022-00724-3
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
Humans
Lenalidomide / therapeutic use
Myelodysplastic Syndromes* / drug therapy
Myelodysplastic Syndromes* / genetics
Thalidomide / therapeutic use
Substances
Thalidomide
Lenalidomide